Ian Jones

Ian Jones is Japan Tobacco International’s (JTI) reduced-risk products vice president. He is based in Geneva, Switzerland. Jones joined JTI in 2006 from the University of Bath in the U.K., where he was a lecturer in developmental neuroscience in the department of biology and biochemistry.

Prior to this, he held postdoctoral research positions at the universities of Bath, Oxford and London, specializing in the anatomical neuropharmacology of nicotinic acetylcholine receptors. Jones holds a doctorate in cell physiology, completed at Imperial College London (1995).